Madrigal pharmaceuticals announces support of fatty liver foundation's screening fund to improve diagnosis and staging of non-alcoholic fatty liver disease (nafld) and non-alcoholic steatohepatitis (nash)

In recognition of liver awareness month, madrigal and fatty liver foundation ring nasdaq closing bell to increase awareness of nafld/nash in recognition of liver awareness month, madrigal and fatty liver foundation ring nasdaq closing bell to increase awareness of nafld/nash
MDGL Ratings Summary
MDGL Quant Ranking